1. A Low Incidence of Nontuberculous Mycobacterial Infections in Pediatric Hematopoietic Stem Cell Transplantation Recipients 
Elif Unal, Catherine Yen, Lisa Saiman, Diane George, Phyllis Della-Latta, Carmella van de Ven, Erin Morris, M. Brigid Bradley, Gustavo Del Toro, James Garvin, Monica Bhatia, Joseph Schwartz, Prakash Satwani, Elizabeth Roman, Erin Cooney, Karen Wolownik, Ria Hawks, Sandra Foley, Mitchell S. Cairo 
Biology of Blood and Marrow Transplantation 
Volume 12, Issue 11, Pages (November 2006)
DOI: /j.bbmt
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
A, Probability of developing grade III-IV aGVHD was determined by the Kaplan-Meier methods in patients after HSCT. B, Probability of developing cGVHD in patients followed ≥18 months after HSCT determined by the Kaplan-Meier method.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Incidence of NTM in all patients (solid line) receiving HSCT and in those after allogeneic HSCT (dashed line).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
A, Probability of overall survival determined by the Kaplan-Meier method in patients after HSCT. B, Probability of overall survival stratified by risk was determined by the Kaplan-Meier method in patients with average risk (solid line) versus those with high risk (dashed line) after HSCT. Allogeneic HSCT recipients were defined as having high-risk disease with ≥1 of the following criteria: leukemia in relapse, leukemia with induction failure, leukemia in third complete remission or beyond, malignant progressive disease, and/or second allogeneic HSCT. All other patients were considered to have average risk. C, Probability of overall survival in patients with NTM from time of HSCT by the Kaplan-Meier method in patients with NTM after HSCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions